Medical Cannabis Is Seeing A Surge In Interest From Key Players


New York, NY May 10, 2019 – Stock Market Press is a leading financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network sees the medical cannabis market expanding across the globe.

More and more countries are allowing research using medical cannabis, both CBD and THC varieties. It has been a long time coming. Passage of the 2018 Farm Bill in the USA and the legalization across Canada are just two examples of restrictions being eased or removed entirely.

Recent research and analysis sees the legal marijuana market topping $145B by 2025. The world of medicine is finally breaking free from the incredible stranglehold that big pharma has had. We are seeing adoption of marijuana in multiple medical categories, from cancers to mental health issues, from chronic pain to seizures. Not only is the demand so great, but the results are so impressive that the FDA recently approved the first CBD containing drug.

All this interest in legal (recreational) and medical cannabis has companies like Tilray Inc. (NASDAQ:TLRY) investing more money into infrastructure for production and manufacturing.

Tilray® Announces Investment to Expand Canadian Production and Manufacturing Footprint to Increase Supply of Medical and Adult-Use Cannabis

Tilray Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced an investment of US$32.6M to increase the company’s Canadian cannabis production and manufacturing footprint by 203,000 square feet across three facilities. This investment will expand Tilray’s total production and manufacturing footprint from 1.1 million to 1.3 million square feet worldwide.

That’s an almost 20% increase across three facilities. Strong indication that the market is set to explode later this year. Further confirmation of this growth comes out of Europe with Aurora Cannabis Inc.’s (NYSE:ACB) recent supply announcement.

Aurora Cannabis Inc Aurora Cannabis Extends Exclusive Supply Relationship with Luxembourg

Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX:ACB) (NYSE:ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that the Company, through its wholly owned subsidiary Aurora Deutschland, has been selected by the Luxembourg Health Ministry as the exclusive supplier in a public bid to supply a second delivery of medical cannabis to Luxembourg.

Under the terms of the bid, the medical cannabis produced will be sold to Luxembourg’s Division de la Pharmacie et des Medicaments, representing the second time the Company has received an order directly from the Luxembourg government. While the initial bid quantities are small, the award confirms Aurora’s position as a trusted and preferred supplier to international jurisdictions and reflects the Company’s ability to work with local governments and regulators in complex, restricted markets.

Medical and recreational cannabis markets continue to attract huge interest as can be seen from just the two examples listed above. The FDA is expected to continue reviewing CBD based drugs which will further push the US Congress to ease restrictions on marijuana. This will be a goldmine to investors.

Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.


Stock Market Press
110 Wall St.
New York, NY 10005

Safe Harbor Statement:

Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer:

SOURCE: Stock Market Press